Moderna (MRNA) FCF Margin (2018 - 2026)
Moderna (MRNA) posted quarterly FCF Margin of 388.28% for Q2 2026, up 26102.0% year-over-year from N/an in Q2 2025, and down 118.26% on a QoQ basis from 177.89% in Q1 2026.
Moderna (MRNA) FCF Margin (2018 - 2026) Analysis & Trends
Moderna has reported FCF Margin for 9 years, with the latest figure at 388.28% in Q2 2026.
- FCF Margin for Q2 2026 came in at 388.28%, up 26102.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 55.83% (up 5755.0% YoY), and the FY2025 annual result was 106.22%, up 1908.0% from the prior year.
- FCF Margin slipped to 388.28% in Q2 2026, from 177.89% in the prior quarter.
- Over five years, FCF Margin peaked at 131.42% in Q4 2025 and troughed at 1068.52% in Q1 2025.
- A 5-year average of 223.15% and a median of 89.41% in 2024 frame the typical range for FCF Margin.
- The widest annual swing landed in 2024, when FCF Margin sank 63772 bps; it then surged 89063 bps in 2026.
- A 5-year view of FCF Margin shows it stood at 30.88% in 2022, then sank by 54 bps to 14.3% in 2023, then jumped by 119 bps to 31.37% in 2024, then jumped by 319 bps to 131.42% in 2025, then tumbled by 395 bps to 388.28% in 2026.
- Per Business Quant data, the three most recent FCF Margin figures were 388.28% in Q2 2026, 177.89% in Q1 2026, and 131.42% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -388.28% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 25.68% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 22.62% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -22.35% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 70.82% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 41.07% |
| 10 | Roivant Sciences | 26.52 Bn | 26.52 Bn | 1.16 Mn | -18,629.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -388.28% |
| Mar 31, 2026 | -170.95% |
| Dec 31, 2025 | 131.42% |
| Sep 30, 2025 | -93.80% |
| Jun 30, 2025 | -597.89% |
| Mar 31, 2025 | -1,068.52% |
| Dec 31, 2024 | 83.44% |
| Sep 30, 2024 | -67.99% |
| Jun 30, 2024 | -604.15% |
| Mar 31, 2024 | -709.58% |
| Dec 31, 2023 | 2.24% |
| Sep 30, 2023 | -89.73% |
| Jun 30, 2023 | -263.66% |
| Mar 31, 2023 | -71.86% |
| Dec 31, 2022 | 30.88% |
| Sep 30, 2022 | 4.85% |
| Jun 30, 2022 | 3.14% |
| Mar 31, 2022 | 44.49% |
| Dec 31, 2021 | 45.28% |
| Sep 30, 2021 | 65.91% |